{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:34:12Z","timestamp":1788910452439,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multimorbidity has great impact on health care. We constructed multimorbidity networks in the general population, extracted subnets focused on common chronic conditions and analysed type 2 diabetes mellitus (T2DM) comorbidity network. We used electronic records from 3,135,948 adult people in Catalonia, Spain (539,909 with T2DM), with at least 2 coexistent chronic conditions within the study period (2006\u20132017). We constructed networks from odds-ratio estimates adjusted by age and sex and considered connections with OR\u2009&gt;\u20091.2 and p-value\u2009&lt;\u20091e-5. Directed networks and trajectories were derived from temporal associations. Interactive networks are freely available in a website with the option to customize characteristics and subnets. The more connected conditions in T2DM undirected network were: complicated hypertension and atherosclerosis\/peripheral vascular disease (degree: 32), cholecystitis\/cholelithiasis, retinopathy and peripheral neuritis\/neuropathy (degree: 31). T2DM has moderate number of connections and centrality but is associated with conditions with high scores in the multimorbidity network (neuropathy, anaemia and digestive diseases), and severe conditions with poor prognosis. The strongest associations from T2DM directed networks were to retinopathy (OR: 23.8), glomerulonephritis\/nephrosis (OR: 3.4), peripheral neuritis\/neuropathy (OR: 2.7) and pancreas cancer (OR: 2.4). Temporal associations showed the relevance of retinopathy in the progression to complicated hypertension, cerebrovascular disease, ischemic heart disease and organ failure.<\/jats:p>","DOI":"10.1038\/s41598-020-59336-1","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T11:03:58Z","timestamp":1581505438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["MorbiNet: multimorbidity networks in adult general population. Analysis of type 2 diabetes mellitus comorbidity"],"prefix":"10.1038","volume":"10","author":[{"given":"Alba","family":"Aguado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Moratalla-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"L\u00f3pez-Simarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"59336_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1370\/afm.272","volume":"3","author":"M Fortin","year":"2005","unstructured":"Fortin, M., Bravo, G., Hudon, C., Vanasse, A. & Lapointe, L. Prevalence of multimorbidity among adults seen in family practice. Ann. Fam. Med. 3, 223\u2013228, https:\/\/doi.org\/10.1370\/afm.272 (2005).","journal-title":"Ann. Fam. Med."},{"key":"59336_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12875-014-0213-6","volume":"16","author":"R Vos","year":"2015","unstructured":"Vos, R., van den Akker, M., Boesten, J., Robertson, C. & Metsemakers, J. Trajectories of multimorbidity: exploring patterns of multimorbidity in patients with more than ten chronic health problems in life course. BMC Fam. Pract. 16, 2, https:\/\/doi.org\/10.1186\/s12875-014-0213-6 (2015).","journal-title":"BMC Fam. Pract."},{"key":"59336_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-530","volume":"14","author":"C Viol\u00e1n","year":"2014","unstructured":"Viol\u00e1n, C. et al. Burden of multimorbidity, socioeconomic status and use of health services across stages of life in urban areas: a cross-sectional study. BMC Public. Health 14, 530, https:\/\/doi.org\/10.1186\/1471-2458-14-530 (2014).","journal-title":"BMC Public. Health"},{"key":"59336_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.amjms.2016.03.004","volume":"352","author":"JS Williams","year":"2016","unstructured":"Williams, J. S. & Egede, L. E. The Association Between Multimorbidity and Quality of Life, Health Status and Functional Disability. Am. J. Med. Sci. 352, 45\u201352, https:\/\/doi.org\/10.1016\/j.amjms.2016.03.004 (2016).","journal-title":"Am. J. Med. Sci."},{"key":"59336_CR5","doi-asserted-by":"publisher","first-page":"e0135947","DOI":"10.1371\/journal.pone.0135947","volume":"10","author":"M Panagioti","year":"2015","unstructured":"Panagioti, M. et al. Multimorbidity and Patient Safety Incidents in Primary Care: A Systematic Review and Meta-Analysis. PLoS One 10, e0135947, https:\/\/doi.org\/10.1371\/journal.pone.0135947 (2015).","journal-title":"PLoS One"},{"key":"59336_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/RMHP.S97248","volume":"9","author":"SM McPhail","year":"2016","unstructured":"McPhail, S. M. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag. Healthc. Policy 9, 143\u2013156, https:\/\/doi.org\/10.2147\/RMHP.S97248 (2016).","journal-title":"Risk Manag. Healthc. Policy"},{"key":"59336_CR7","doi-asserted-by":"publisher","first-page":"e1000353","DOI":"10.1371\/journal.pcbi.1000353","volume":"5","author":"CA Hidalgo","year":"2009","unstructured":"Hidalgo, C. A., Blumm, N., Barab\u00e1si, A. L. & Christakis, N. A. A dynamic network approach for the study of human phenotypes. PLoS Comput. Biol. 5, e1000353, https:\/\/doi.org\/10.1371\/journal.pcbi.1000353 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"59336_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7150\/ijms.13456","volume":"13","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Comorbidity Analysis According to Sex and Age in Hypertension Patients in China. Int. J. Med. Sci. 13, 99\u2013107, https:\/\/doi.org\/10.7150\/ijms.13456 (2016).","journal-title":"Int. J. Med. Sci."},{"key":"59336_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1183\/09031936.00171614","volume":"46","author":"MJ Divo","year":"2015","unstructured":"Divo, M. J. et al. COPD comorbidities network. Eur. Respir. J. 46, 640\u2013650, https:\/\/doi.org\/10.1183\/09031936.00171614 (2015).","journal-title":"Eur. Respir. J."},{"key":"59336_CR10","doi-asserted-by":"publisher","first-page":"e112734","DOI":"10.1371\/journal.pone.0112734","volume":"9","author":"R Goekoop","year":"2014","unstructured":"Goekoop, R. & Goekoop, J. G. A network view on psychiatric disorders: network clusters of symptoms as elementary syndromes of psychopathology. PLoS One 9, e112734, https:\/\/doi.org\/10.1371\/journal.pone.0112734 (2014).","journal-title":"PLoS One"},{"key":"59336_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijmedinf.2017.09.014","volume":"108","author":"P Kalgotra","year":"2017","unstructured":"Kalgotra, P., Sharda, R. & Croff, J. M. Examining health disparities by gender: A multimorbidity network analysis of electronic medical record. Int. J. Med. Inf. 108, 22\u201328, https:\/\/doi.org\/10.1016\/j.ijmedinf.2017.09.014 (2017).","journal-title":"Int. J. Med. Inf."},{"key":"59336_CR12","unstructured":"International-Diabetes-Federation. (International Diabetes Federation, Brussels, Belgium, 2017)."},{"key":"59336_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/17843286.2017.1348710","volume":"73","author":"MP Hermans","year":"2018","unstructured":"Hermans, M. P. & Dath, N. Prevalence and co-prevalence of comorbidities in Belgian patients with type 2 diabetes mellitus: a transversal, descriptive study. Acta. Clin. Belg. 73, 68\u201374, https:\/\/doi.org\/10.1080\/17843286.2017.1348710 (2018).","journal-title":"Acta. Clin. Belg."},{"issue":"1","key":"59336_CR14","doi-asserted-by":"publisher","first-page":"2235042X1880165","DOI":"10.1177\/2235042X18801658","volume":"8","author":"Sandra Pouplier","year":"2018","unstructured":"Pouplier, S. et al. The development of multimorbidity during 16 years after diagnosis of type 2 diabetes. J Comorb 8, 2235042X18801658, https:\/\/doi.org\/10.1177\/2235042X18801658 (2018).","journal-title":"Journal of Comorbidity"},{"key":"59336_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1475-2840-12-47","volume":"12","author":"J Wasem","year":"2013","unstructured":"Wasem, J. et al. Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy\u2013an analysis of the DiaRegis registry. Cardiovasc. Diabetol. 12, 47, https:\/\/doi.org\/10.1186\/1475-2840-12-47 (2013).","journal-title":"Cardiovasc. Diabetol."},{"key":"59336_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-23","volume":"13","author":"M O\u2019Shea","year":"2013","unstructured":"O\u2019Shea, M., Teeling, M. & Bennett, K. The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims database. BMC Health Serv. Res. 13, 23, https:\/\/doi.org\/10.1186\/1472-6963-13-23 (2013).","journal-title":"BMC Health Serv. Res."},{"key":"59336_CR17","doi-asserted-by":"publisher","first-page":"e0209585","DOI":"10.1371\/journal.pone.0209585","volume":"13","author":"JI Chiang","year":"2018","unstructured":"Chiang, J. I. et al. Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review. PLoS One 13, e0209585, https:\/\/doi.org\/10.1371\/journal.pone.0209585 (2018).","journal-title":"PLoS One"},{"key":"59336_CR18","unstructured":"Health, W. & Organization. ICD-10 International Statistical Classification of Diseases and Related Health Problems. 10th revision. (2016)."},{"key":"59336_CR19","unstructured":"International, W. & Committee, C. (Oxford University Press, 1998)."},{"key":"59336_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/fampra\/cmh407","volume":"21","author":"J O\u2019Halloran","year":"2004","unstructured":"O\u2019Halloran, J., Miller, G. C. & Britt, H. Defining chronic conditions for primary care with ICPC-2. Fam. Pract. 21, 381\u2013386, https:\/\/doi.org\/10.1093\/fampra\/cmh407 (2004).","journal-title":"Fam. Pract."},{"key":"59336_CR21","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.1528707","volume":"21","author":"X Zhu","year":"2007","unstructured":"Zhu, X., Gerstein, M. & Snyder, M. Getting connected: analysis and principles of biological networks. Genes. Dev. 21, 1010\u20131024, https:\/\/doi.org\/10.1101\/gad.1528707 (2007).","journal-title":"Genes. Dev."},{"key":"59336_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-1-24","volume":"1","author":"J Dong","year":"2007","unstructured":"Dong, J. & Horvath, S. Understanding network concepts in modules. BMC Syst. Biol. 1, 24, https:\/\/doi.org\/10.1186\/1752-0509-1-24 (2007).","journal-title":"BMC Syst. Biol."},{"key":"59336_CR23","doi-asserted-by":"publisher","first-page":"e0197595","DOI":"10.1371\/journal.pone.0197595","volume":"13","author":"P Devkota","year":"2018","unstructured":"Devkota, P., Danzi, M. C. & Wuchty, S. Beyond degree and betweenness centrality: Alternative topological measures to predict viral targets. PLoS One 13, e0197595, https:\/\/doi.org\/10.1371\/journal.pone.0197595 (2018).","journal-title":"PLoS One"},{"key":"59336_CR24","doi-asserted-by":"crossref","unstructured":"Freeman, L. Vol. 1, 215\u2013239 (Social Networks, 1978).","DOI":"10.1016\/0378-8733(78)90021-7"},{"key":"59336_CR25","unstructured":"Aguado, A., Moratalla, F., L\u00f3pez-Simarro, F. & Moreno, V. MorbiNet: Multimorbidity Networks in Adult General Population. MorbiNet v 2.2. https:\/\/www.morbinet.org Accessed 1 Oct 2019 (2019)."},{"key":"59336_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S0140-6736(06)69700-6","volume":"368","author":"G Danaei","year":"2006","unstructured":"Danaei, G., Lawes, C. M., Vander Hoorn, S., Murray, C. J. & Ezzati, M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368, 1651\u20131659, https:\/\/doi.org\/10.1016\/S0140-6736(06)69700-6 (2006).","journal-title":"Lancet"},{"key":"59336_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3904\/kjim.2012.27.2.197","volume":"27","author":"HS Kim","year":"2012","unstructured":"Kim, H. S., Shin, A. M., Kim, M. K. & Kim, Y. N. Comorbidity study on type 2 diabetes mellitus using data mining. Korean J. Intern. Med. 27, 197\u2013202, https:\/\/doi.org\/10.3904\/kjim.2012.27.2.197 (2012).","journal-title":"Korean J. Intern. Med."},{"key":"59336_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","volume":"2","author":"GBoMRFfCD Collaboration","year":"2014","unstructured":"Collaboration, G. Bo. M. R. Ff. C. D. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2, 634\u2013647, https:\/\/doi.org\/10.1016\/S2213-8587(14)70102-0 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"59336_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0561-1","volume":"15","author":"HE Moss","year":"2015","unstructured":"Moss, H. E. Retinal Vascular Changes are a Marker for Cerebral Vascular Diseases. Curr. Neurol. Neurosci. Rep. 15, 40, https:\/\/doi.org\/10.1007\/s11910-015-0561-1 (2015).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"59336_CR30","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1001\/archinte.163.20.2505","volume":"163","author":"SE Moss","year":"2003","unstructured":"Moss, S. E., Klein, R., Klein, B. E. & Wong, T. Y. Retinal vascular changes and 20-year incidence of lower extremity amputations in a cohort with diabetes. Arch. Intern. Med. 163, 2505\u20132510, https:\/\/doi.org\/10.1001\/archinte.163.20.2505 (2003).","journal-title":"Arch. Intern. Med."},{"key":"59336_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1001\/jamaophthalmol.2017.0988","volume":"135","author":"J Xie","year":"2017","unstructured":"Xie, J. et al. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 135, 586\u2013593, https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.0988 (2017).","journal-title":"JAMA Ophthalmol."},{"key":"59336_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-14-94","volume":"14","author":"L Li","year":"2014","unstructured":"Li, L., Wan, X. H. & Zhao, G. H. Meta-analysis of the risk of cataract in type 2 diabetes. BMC Ophthalmol. 14, 94, https:\/\/doi.org\/10.1186\/1471-2415-14-94 (2014).","journal-title":"BMC Ophthalmol."},{"key":"59336_CR33","doi-asserted-by":"publisher","first-page":"e102972","DOI":"10.1371\/journal.pone.0102972","volume":"9","author":"M Zhou","year":"2014","unstructured":"Zhou, M., Wang, W., Huang, W. & Zhang, X. Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS One 9, e102972, https:\/\/doi.org\/10.1371\/journal.pone.0102972 (2014).","journal-title":"PLoS One"},{"key":"59336_CR34","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","volume":"65","author":"JM Hazlehurst","year":"2016","unstructured":"Hazlehurst, J. M., Woods, C., Marjot, T., Cobbold, J. F. & Tomlinson, J. W. Non-alcoholic fatty liver disease and diabetes. Metab. 65, 1096\u20131108, https:\/\/doi.org\/10.1016\/j.metabol.2016.01.001 (2016).","journal-title":"Metab."},{"key":"59336_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel, V. T. & Shulman, G. I. Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab. 27, 22\u201341, https:\/\/doi.org\/10.1016\/j.cmet.2017.08.002 (2018).","journal-title":"Cell Metab."},{"key":"59336_CR36","doi-asserted-by":"publisher","first-page":"e0216062","DOI":"10.1371\/journal.pone.0216062","volume":"14","author":"YG Lee","year":"2019","unstructured":"Lee, Y. G. et al. Risk factors for incident anemia of chronic diseases: A cohort study. PLoS One 14, e0216062, https:\/\/doi.org\/10.1371\/journal.pone.0216062 (2019).","journal-title":"PLoS One"},{"key":"59336_CR37","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jdiacomp.2017.04.002","volume":"31","author":"R Gauci","year":"2017","unstructured":"Gauci, R., Hunter, M., Bruce, D. G., Davis, W. A. & Davis, T. M. E. Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis. J. Diabetes Complications 31, 1169\u20131174, https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.002 (2017).","journal-title":"J. Diabetes Complications"},{"key":"59336_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.acvd.2015.01.009","volume":"108","author":"M Tadic","year":"2015","unstructured":"Tadic, M. & Cuspidi, C. Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice. Arch. Cardiovasc. Dis. 108, 269\u2013276, https:\/\/doi.org\/10.1016\/j.acvd.2015.01.009 (2015).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"59336_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejim.2015.02.005","volume":"26","author":"E Alonso-Mor\u00e1n","year":"2015","unstructured":"Alonso-Mor\u00e1n, E. et al. Multimorbidity in people with type 2 diabetes in the Basque Country (Spain): Prevalence, comorbidity clusters and comparison with other chronic patients. Eur. J. Intern. Med. 26, 197\u2013202, https:\/\/doi.org\/10.1016\/j.ejim.2015.02.005 (2015).","journal-title":"Eur. J. Intern. Med."},{"key":"59336_CR40","doi-asserted-by":"publisher","first-page":"g7371","DOI":"10.1136\/bmj.g7371","volume":"350","author":"WC Liao","year":"2015","unstructured":"Liao, W. C. et al. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ 350, g7371, https:\/\/doi.org\/10.1136\/bmj.g7371 (2015).","journal-title":"BMJ"},{"key":"59336_CR41","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1515\/cclm-2017-0982","volume":"56","author":"E Anastasi","year":"2018","unstructured":"Anastasi, E. et al. Linking type 2 diabetes and gynecological cancer: an introductory overview. Clin. Chem. Lab. Med. 56, 1413\u20131425, https:\/\/doi.org\/10.1515\/cclm-2017-0982 (2018).","journal-title":"Clin. Chem. Lab. Med."},{"key":"59336_CR42","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3748\/wjg.v19.i6.936","volume":"19","author":"JM Yoon","year":"2013","unstructured":"Yoon, J. M., Son, K. Y., Eom, C. S., Durrance, D. & Park, S. M. Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis. World J. Gastroenterol. 19, 936\u2013945, https:\/\/doi.org\/10.3748\/wjg.v19.i6.936 (2013).","journal-title":"World J. Gastroenterol."},{"key":"59336_CR43","doi-asserted-by":"publisher","first-page":"44881","DOI":"10.18632\/oncotarget.16487","volume":"8","author":"ZF Miao","year":"2017","unstructured":"Miao, Z. F. et al. Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies. Oncotarget 8, 44881\u201344892, https:\/\/doi.org\/10.18632\/oncotarget.16487 (2017).","journal-title":"Oncotarget"},{"key":"59336_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000484283","volume":"192","author":"C King","year":"2018","unstructured":"King, C. et al. Uric Acid as a Cause of the Metabolic Syndrome. Contrib. Nephrol. 192, 88\u2013102, https:\/\/doi.org\/10.1159\/000484283 (2018).","journal-title":"Contrib. Nephrol."},{"key":"59336_CR45","doi-asserted-by":"publisher","first-page":"e1004125","DOI":"10.1371\/journal.pcbi.1004125","volume":"11","author":"P Klimek","year":"2015","unstructured":"Klimek, P., Kautzky-Willer, A., Chmiel, A., Schiller-Fr\u00fchwirth, I. & Thurner, S. Quantification of diabetes comorbidity risks across life using nation-wide big claims data. PLoS Comput. Biol. 11, e1004125, https:\/\/doi.org\/10.1371\/journal.pcbi.1004125 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"59336_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11892-015-0704-4","volume":"16","author":"J Suvisaari","year":"2016","unstructured":"Suvisaari, J., Kein\u00e4nen, J., Eskelinen, S. & Mantere, O. Diabetes and Schizophrenia. Curr. Diab. Rep. 16, 16, https:\/\/doi.org\/10.1007\/s11892-015-0704-4 (2016).","journal-title":"Curr. Diab. Rep."},{"key":"59336_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/dme.12855","volume":"33","author":"MH Pourmemari","year":"2016","unstructured":"Pourmemari, M. H. & Shiri, R. Diabetes as a risk factor for carpal tunnel syndrome: a systematic review and meta-analysis. Diabet. Med. 33, 10\u201316, https:\/\/doi.org\/10.1111\/dme.12855 (2016).","journal-title":"Diabet. Med."},{"key":"59336_CR48","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1183\/09031936.00229714","volume":"45","author":"PJ Barnes","year":"2015","unstructured":"Barnes, P. J. Mechanisms of development of multimorbidity in the elderly. Eur. Respir. J. 45, 790\u2013806, https:\/\/doi.org\/10.1183\/09031936.00229714 (2015).","journal-title":"Eur. Respir. J."},{"key":"59336_CR49","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1185\/03007995.2016.1168291","volume":"32","author":"K Iglay","year":"2016","unstructured":"Iglay, K. et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr. Med. Res. Opin. 32, 1243\u20131252, https:\/\/doi.org\/10.1185\/03007995.2016.1168291 (2016).","journal-title":"Curr. Med. Res. Opin."},{"key":"59336_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/13814788.2012.714768","volume":"19","author":"C Teljeur","year":"2013","unstructured":"Teljeur, C., Smith, S. M., Paul, G., Kelly, A. & O\u2019Dowd, T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur. J. Gen. Pract. 19, 17\u201322, https:\/\/doi.org\/10.3109\/13814788.2012.714768 (2013).","journal-title":"Eur. J. Gen. Pract."},{"key":"59336_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/02813432.2015.1132886","volume":"34","author":"V Brali\u0107 Lang","year":"2016","unstructured":"Brali\u0107 Lang, V. & Bergman Markovi\u0107, B. Prevalence of comorbidity in primary care patients with type 2 diabetes and its association with elevated HbA1c: A cross-sectional study in Croatia. Scand. J. Prim. Health Care 34, 66\u201372, https:\/\/doi.org\/10.3109\/02813432.2015.1132886 (2016).","journal-title":"Scand. J. Prim. Health Care"},{"key":"59336_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34361-3","volume":"8","author":"A Amell","year":"2018","unstructured":"Amell, A. et al. Disease networks identify specific conditions and pleiotropy influencing multimorbidity in the general population. Sci. Rep. 8, 15970, https:\/\/doi.org\/10.1038\/s41598-018-34361-3 (2018).","journal-title":"Sci. Rep."},{"key":"59336_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5022","volume":"5","author":"AB Jensen","year":"2014","unstructured":"Jensen, A. B. et al. Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients. Nat. Commun. 5, 4022, https:\/\/doi.org\/10.1038\/ncomms5022 (2014).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59336-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:49:29Z","timestamp":1670309369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59336-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59336"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59336-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2416"}}